News and Announcements
What You Need to Know about ESG Investing
- Published November 03, 2022 7:50AM UTC
- Publisher Maan Perez
- Categories Venture Investor Interviews
ESG stands for Environmental, Social and Governance. It makes up for factors that form part of any new or existing venture analysis. Investors are increasingly considering these factors as part of their analysis, especially on the institutional/VC side.
Because of this, it is important to have a grasp on what exactly ESG entails, and how to ensure the venture you deal with is complying. This will enable the venture to not be overlooked for current and future funding rounds, as well as ensuring they meet the new demands of the modern end-user.
Panelists:
Matthew Pryor – Co-Founder of Tenacious Ventures
Tim Neale – Founder of DataFarming
Irfan Malik -Co-Founder of inQ Innovation Global
Cal Archibald – Director at Beanstalk AgTech
Lisa Fedorenko – Investment Manager at Alberts
Looking for new investment opportunities? Click here to browse hundreds of companies, connect with their CEO and create your personalised deal flow.
Your AI Driven matchmaking platform
With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.
Venture Investor Interviews
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
